Cancer Clinical Trials at the Koontz Center
The Koontz Center for Advanced Breast Cancer is the region’s first and only program dedicated to the treatment of metastatic breast cancer.
Currently Enrolling
The Koontz Center is currently enrolling patients in the following trials specifically targeting advanced breast cancer:
- Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)
- SGNTUC-025-A single arm, open label phase 2 study of tucatinib in combination with trastuzumab deruxtecan in subjects with previously treated unresectable locally-advanced or metastatic Her2+ breast cancer
- A compassionate use study of leronlimab (PRO140) plus treatment of physician's choice in patients with CCR5+ metastatic triple-negative breast cancer